In situ production of ROS in the skin by photodynamic therapy as a powerful tool in clinical dermatology. (Q38898468)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

review article

1 reference

title

In situ production of ROS in the skin by photodynamic therapy as a powerful tool in clinical dermatology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Adrian Alegre-Sanchez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

David Saceda-Corralo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

María I Calvo-Sánchez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Sergio Vano-Galvan

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Jesús Espada

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Oscar M Moreno-Arrones

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Diego Buendia-Castaño

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Cristina Pindado-Ortega

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Pablo Fernandez-Gonzalez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Kyra Velazquez-Kennedy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Antonio Harto-Castaño

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Bibiana Perez-Garcia

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Lorea Bagazgoitia

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Pedro Jaen-Olasolo

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

publication date

12 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

190-202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

Photodynamic therapy in dermatology: a review

18 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photosensitization with derivatives of haematoporphyrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photosensitizers for photodynamic therapy of cutaneous disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy in dermatology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Relationship of delta-aminolevulinic acid-induced protoporphyrin IX levels to mitochondrial content in neoplastic cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photogeneration of singlet oxygen (1O2) and free radicals (Sen*-, O2*-) by tetra-brominated hypocrellin B derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Protein oxidation and proteolysis by the nonradical oxidants singlet oxygen or peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

The role of subcellular localization in initiation of apoptosis by photodynamic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy with pyropheophorbide-a methyl ester in human lung carcinoma cancer cell: efficacy, localization and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Targeting of the vascular system of solid tumours by photodynamic therapy (PDT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Induction of tumor immunity by photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy and antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic photorejuvenation of the face with a combination of microneedling, red light, and broadband pulsed light

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Combined carbon dioxide laser with photodynamic therapy for nodular and superficial basal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Intense pulse light and 5-ALA PDT: phototoxic effects in vitro depend on the spectral overlap with protoporphyrine IX but do not match cut-off filter notations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Pain caused by photodynamic therapy of skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Important factors for pain during photodynamic therapy for actinic keratosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Pain associated with aminolevulinic acid-photodynamic therapy of skin disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Predictors of pain associated with photodynamic therapy: a retrospective study of 658 treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic k

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Comparative study between cold air analgesia and supraorbital and supratrochlear nerve block for the management of pain during photodynamic therapy for actinic keratoses of the frontotemporal zone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Solar (actinic) keratosis is squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

The natural history of actinic keratosis: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: Oncologic and infectious indications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Methyl-aminolevulinate photodynamic therapy for the treatment of erythroplasia of Queyrat in 23 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Effectiveness of photodynamic therapy for mammary and extra-mammary Paget's disease: a state of the science review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy with M-ALA as non surgical treatment option in patients with primary extramammary Paget's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Clinical and immunohistochemical assessment of vulval intraepithelial neoplasia following photodynamic therapy using a novel bioadhesive patch-type system loaded with 5-aminolevulinic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Efficacy of topical photodynamic therapy for keratoacanthomas: a case-series of four patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

New photodynamic therapy protocol to treat AIDS-related Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Classic Kaposi sarcoma treated with intralesional 5-aminolevulinic acid injection photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

European guidelines for topical photodynamic therapy part 2: emerging indications--field cancerization, photorejuvenation and inflammatory/infective dermatoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Aminolevulinic acid photodynamic therapy for hidradenitis suppurativa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Treatment of hidradenitis suppurativa with intralesional photodynamic therapy using a laser diode attached to an optical cable: a promising new approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Topical photodynamic therapy with methyl aminolevulinate to treat sebaceous hyperplasia in an organ transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Treatment of folliculitis decalvans with photodynamic therapy: Results in 10 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Chondrodermatitis nodularis helicis successfully treated with photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Clinical improvement in Darier's disease with photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Experience with photodynamic therapy in Hailey-Hailey disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Primary follicular mucinosis: excellent response to treatment with photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy for necrobiosis lipoidica is an unpredictable option: three cases with different results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Treatment of recalcitrant erosive vulvar lichen sclerosus with photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy for the treatment of morphoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Topical methyl aminolevulinate photodynamic therapy for the treatment of folliculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Mycobacterium marinum infection cured by photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic action of red light for treatment of erythrasma: preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment of condylomata acuminata: a comparative, randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

High-intensity laser and photodynamic therapy as a treatment for recurrent herpes labialis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Treatment of verrucae vulgaris and molluscum contagiosum with photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Topical photodynamic therapy with methyl aminolevulinate may be an alternative therapeutic option for the recalcitrant Malassezia folliculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Cutaneous sporotrichosis treated with photodynamic therapy: an in vitro and in vivo study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Successful treatment of cutaneous leishmaniasis with intralesional aminolevulinic acid photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Clinical implications of aging skin: cutaneous disorders in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

7 January 2021

Photoaging of human skin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Molecular basis of sun-induced premature skin ageing and retinoid antagonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Matrix metalloproteinases in skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photorejuvenation with topical methyl aminolevulinate and red light: a randomized, prospective, clinical, histopathologic, and morphometric study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Molecular effects of photodynamic therapy for photoaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photodynamic Photorejuvenation: A Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Skin fluorescence controlled photodynamic photorejuvenation (wrinkle reduction).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Comparative split-face study of 5-aminolevulinic acid photodynamic therapy with intense pulsed light for photorejuvenation of Asian skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photorejuvenation induced by 5-aminolevulinic acid photodynamic therapy in patients with actinic keratosis: a histologic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Topical 5-aminolevulinic acid with intense pulsed light versus intense pulsed light for photodamage in Chinese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

The effect of increasing fluence on the treatment of actinic keratosis and photodamage by photodynamic therapy with 5-aminolevulinic acid and intense pulsed light

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

A prospective split-face double-blind randomized placebo-controlled trial to assess the efficacy of methyl aminolevulinate + red-light in patients with facial photodamage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Protoporphyrin IX-dependent photodynamic production of endogenous ROS stimulates cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Photoactivation of ROS Production In Situ Transiently Activates Cell Proliferation in Mouse Skin and in the Hair Follicle Stem Cell Niche Promoting Hair Growth and Wound Healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

Epidermal homeostasis: a balancing act of stem cells in the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2016.07.008

10.1016/J.YMETH.2016.07.008

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27422482%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference